Celltech
Celltech[edit | edit source]
Celltech was a pioneering biotechnology company based in the United Kingdom. Founded in 1980, it was one of the first biotechnology companies in Europe and played a significant role in the development of the biotechnology industry in the UK.
History[edit | edit source]
Celltech was established in 1980 by a group of scientists and entrepreneurs who recognized the potential of biotechnology to transform medicine and healthcare. The company initially focused on the development of monoclonal antibodies and other innovative therapeutic approaches.
In the 1990s, Celltech expanded its research and development efforts, entering into collaborations with major pharmaceutical companies to advance its drug discovery programs. The company became known for its work in immunology and oncology, developing several promising drug candidates.
Acquisitions and Mergers[edit | edit source]
In 1999, Celltech acquired Chiroscience, another UK-based biotechnology company, which helped to strengthen its position in the industry. This acquisition was part of a broader strategy to expand its capabilities and pipeline.
In 2004, Celltech itself was acquired by the Belgian pharmaceutical company UCB. This acquisition marked the end of Celltech as an independent entity, but its legacy continued as part of UCB's global operations.
Contributions to Biotechnology[edit | edit source]
Celltech made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. The company's research efforts led to the discovery of several important therapeutic agents that have been used in the treatment of various diseases.
The company's work in biopharmaceuticals helped to establish the UK as a leader in the biotechnology sector, paving the way for future innovations and developments in the field.
Legacy[edit | edit source]
Although Celltech no longer exists as an independent company, its impact on the biotechnology industry is still felt today. The company's pioneering efforts in drug discovery and development have influenced many of the current practices and technologies used in the field.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
